Michael Wheeler MP: written questions
Michael Wheeler MP: full overview
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
13 published records · newest first.
Written questions
Medical Treatments: British Nationals AbroadDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7321More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve patient awareness of the potential risks of undergoing medical procedures overseas.
Answer: The Department has recently updated guidance that advises anyone considering a procedure abroad to carefully research the treatment in question, the qualifications of their clinician, and the regulations that apply in any specific country. The Department ...
Answered 15 Jun 2026
Original Parliament recordMedical Treatments: British Nationals AbroadDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7320More
Question: To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people travelling abroad for medical treatment; what estimate he has made of the number of complications caused by overseas treatment requirin
Answer: The Department does not have data on the number of people travelling abroad for medical treatment, of complications caused by overseas treatment, or of the overall costs to the National Health Service for treating complications from cosmetic procedures co...
Answered 15 Jun 2026
Original Parliament recordAmyloidosis: DiagnosisDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7319More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of trends in the level of provision of SAP scanning for amyloidosis diagnosis for patients; and what assessment he has made of potential challenges to
Answer: The Government is committed to improving the lives of those living with rare diseases, such as amyloidosis, under the UK Rare Diseases Framework. We published the fifth annual England action plan in February 2026, where we report on the steps we have take...
Answered 15 Jun 2026
Original Parliament recordAmyloidosis: DiagnosisDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7318More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to SAP scanning for amyloidosis diagnosis for NHS patients in England; and what steps he is taking to ensure such diagnostic testin
Answer: The Government is committed to improving the lives of those living with rare diseases, such as amyloidosis, under the UK Rare Diseases Framework. We published the fifth annual England action plan in February 2026, where we report on the steps we have take...
Answered 15 Jun 2026
Original Parliament recordNHS: Redundancy PayDepartment of Health and Social CareTabled 25 Mar 2026AnsweredUIN 123859More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 March 2026 to Question 115765, on NHS: Redundancy Pay, whether he will consider giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory
Answer: The Department has received correspondence from the NHS Staff Council on this matter.The Department considers all requests from the NHS Staff Council for a mandate to negotiate and make changes to the NHS Terms and Conditions of Service on a case-by-case ...
Answered 14 Apr 2026
Original Parliament recordNHS: Redundancy PayDepartment of Health and Social CareTabled 24 Feb 2026AnsweredUIN 115765More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory redundancy payments with trade unio
Answer: This specific assessment has not been made.Partial retirement does not mean that National Health Service staff are ineligible for redundancy payments. However, taking partial retirement may change the way in which contractual redundancy payments are calcu...
Answered 18 Mar 2026
Original Parliament recordIdiopathic Pulmonary Fibrosis: DrugsDepartment of Health and Social CareTabled 23 Feb 2026AnsweredUIN 115271More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes
Answer: Subject to licensing, the National Institute for Health and Care Excellence (NICE) currently expects to publish final guidance on nerandomilast in September 2026. In formulating its recommendations, NICE's independent Appraisal Committee expects to hold i...
Answered 2 Mar 2026
Original Parliament recordIdiopathic Pulmonary Fibrosis: DrugsDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110593More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
Answer: No specific consideration of the implications of the United Kingdom and United States’ Economic Prosperity Deal for the approval of Jascayd (nernadomilast) has been made. The changes that we are making to the way in which the National Institute for Health...
Answered 12 Feb 2026
Original Parliament recordIdiopathic Pulmonary Fibrosis: DrugsDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110592More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has an estimate of the earliest possible date Jascayd (nerandomilast) could be available to idiopathic pulmonary fibrosis patients.
Answer: Nerandomilast does not currently have a United Kingdom marketing authorisation for use in the treatment of idiopathic pulmonary fibrosis. It is currently being evaluated by the National Institute for Health and Care Excellence (NICE) which makes recommend...
Answered 12 Feb 2026
Original Parliament recordMidwives and Nurses: RecruitmentDepartment of Health and Social CareTabled 28 Jan 2026AnsweredUIN 109381More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of extending the Graduate Guarantee scheme for newly qualified nurses and midwives in England to include graduates who qualified prio
Answer: No assessment has been made. There are no plans to extend the Graduate Guarantee to include graduates who qualified prior to 2024.
Answered 11 Feb 2026
Original Parliament recordMidwives and Nurses: RecruitmentDepartment of Health and Social CareTabled 28 Jan 2026AnsweredUIN 109380More
Question: To ask the Secretary of State for Health and Social Care, how the eligibility criteria for the Graduate Guarantee scheme for newly qualified nurses and midwives in England was determined.
Answer: The Graduate Guarantee is a workforce measure aimed at improving the access and transition into employment for newly qualified nurses and midwives in England.It is aimed at ensuring that the 2025 cohort has opportunities to apply for roles across the heal...
Answered 11 Feb 2026
Original Parliament recordNurses: SchoolsDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67705More
Question: To ask the Secretary of State for Health and Social Care, what plans his Department has to increase the recruitment and retention of school nurses; how much funding was allocated for school nursing services in the (a) 2024-25 and (b) 2025-26 financial yea
Answer: The child health workforce, including school nurses, is central to how we support families to give their children the best start in life. We will ensure we have the staff we need so that children and their families are cared for by the right professional,...
Answered 25 Jul 2025
Original Parliament recordHealth Services: ApprenticesDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67704More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the planned changes to funding for Level 7 apprenticeships for Specialist Community Public Health Nurses after January 2026; and w
Answer: While the Department for Education has announced that the funding arrangements for Level 7 apprenticeships are changing, we are working closely with partners to ensure that health and social care has access to the skilled workforce patients need, includin...
Answered 22 Jul 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →